Document Detail


Daily interpersonal conflict predicts masked hypertension in an urban sample.
MedLine Citation:
PMID:  20616788     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Masked hypertension (MH) is a risk factor for cardiovascular and cerebrovascular diseases. However, little is known about the effect of psychosocial stressors on MH.
METHODS: Daily interpersonal conflict was examined as a predictor of elevated ambulatory blood pressure (ABP) in a community sample of 240 unmedicated black and Latino(a) adults (63% women; mean age 36 years) who had optimal office blood pressure (BP) readings (≤120/80 mm Hg). Electronic diaries were used to assess daily interpersonal conflict (i.e., perceptions of being treated unfairly/harassed during social interactions). Participants rated the degree to which they experienced each interaction as unfair or harassing on a scale of 1-100. Systolic and diastolic ABP (SysABP and DiaABP, respectively) were collected using a validated 24-h ABP monitor. Participants were classified as having marked MH (MMH) if the average of all readings obtained yielded SysABP: ≥135 mm Hg or DiaABP: ≥85 mm Hg. Logistic regression was used to examine whether daily interpersonal conflict is an independent predictor of MMH.
RESULTS: This form of MMH (i.e., optimal office BP plus elevated ABP) was present in 21% of participants (n = 50). Those with MMH (vs. without) were significantly more likely to be men (P < 0.001). Daily harassment and unfair treatment scores were significant predictors of MMH group status (P < 0.05). Participants with harassment scores >30 were significantly more likely to be in the MMH group.
CONCLUSION: MH may be a concern, even for patients with optimal office BP. Evaluating exposure to psychosocial stressors, including routine levels of interpersonal conflict may help to identify those patients who might benefit from further clinical follow-up.
Authors:
Antoinette M Schoenthaler; Joseph Schwartz; Andrea Cassells; Jonathan N Tobin; Elizabeth Brondolo
Related Documents :
20044738 - Cross-sectional characterization of all classes of antihypertensives in terms of centra...
8345498 - Nocturnal hypotension and ace inhibitors.
18380058 - Recent update in the management of hypertension.
8583468 - Paraguayan national blood pressure study: prevalence of hypertension in the general pop...
10661478 - Cardiac function in dialysis patients evaluated by doppler echocardiography and its rel...
16573478 - Preload response in patients after cardiac surgery: a comparison of systolic blood pres...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-07-08
Journal Detail:
Title:  American journal of hypertension     Volume:  23     ISSN:  1941-7225     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-20     Completed Date:  2011-01-07     Revised Date:  2011-06-30    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1082-8     Citation Subset:  IM    
Affiliation:
Department of Medicine, Center for Healthful Behavior Change, New York University School of Medicine, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Continental Ancestry Group
Blood Pressure / physiology
Conflict (Psychology)*
Ethnic Groups
Female
Hispanic Americans
Humans
Hypertension / epidemiology*,  physiopathology,  psychology*
Interpersonal Relations*
Logistic Models
Male
Medical Records
New York City / epidemiology
Social Behavior
Social Class
Social Environment
Socioeconomic Factors
Urban Population
Grant Support
ID/Acronym/Agency:
R01 HL068590/HL/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals wi...
Next Document:  Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.